Biggest News Aggregation in the World
📰 Presents News

Page 87 - Presents News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Presents. Real-time updates on events, politics, business and more.

Shanghai Cellular Biopharmaceutical Group Ltd.: Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting

Promising anti-tumor activity reported for C-CAR031, a novel Glypican 3 (GPC3)-targeting cell therapy designed by AstraZeneca SHANGHAI, April 17, 2023 /PRNewswire/ -- Shanghai Cellular
United States Orange County Convention Center Sarah Kelly Company Contact American Association For Cancer Research Prnewswire Shanghai Cellular Biopharmaceutical Group Ltd

GRAIL, LLC: GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research (AACR) Annual Meeting 2023

GRAIL's Methylation Assay Had 92% Cancer Detection Rate Across Six Hematologic Malignancies With 96% Accuracy in Determining the Hematologic Malignancy Subtype Findings Support Use of GRAIL's Methylation
North Carolina United States United Kingdom Jeffrey Venstrom Cammy Duong Trish Rowland

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

NuCana plc: NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action

NUC-7738 Reduces Secreted Forms of PD-L1 Indicating Potential Synergy with Checkpoint Inhibitors NUC-7738 Decreases Glutaminase in vitro and in Cancer Tissue Demonstrating Potential for Anti-Cancer
United States Hughs Griffith Chris Brinzey Company Annual Report On Form American Association Of Cancer Research Exchange Commission

MiNA Therapeutics Limited: MiNA Therapeutics Presents Late-Breaking Positive Phase 1b Data for MTL-CEBPA in Combination with an Anti-PD1 Checkpoint Inhibitor at the Annual American Association of Cancer Research (AACR) Meeting

Findings validate clinical proof of mechanism of MTL-CEBPA as a combination therapy in solid tumor cancers Company to initiate out-licensing activities of its immuno-oncology portfolio, including
United States United Kingdom Robert Habib Mike Beyer Peter Bains Drug Administration

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science